BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 30855427)

  • 1. The Distributional Characteristic and Growing Trend of Pancreatic Cancer in China.
    Zhao C; Gao F; Li Q; Liu Q; Lin X
    Pancreas; 2019 Mar; 48(3):309-314. PubMed ID: 30855427
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pancreatic Cancer Mortality in China: Characteristics and Prediction.
    Jia X; Du P; Wu K; Xu Z; Fang J; Xu X; Lin K
    Pancreas; 2018 Feb; 47(2):233-237. PubMed ID: 29303909
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Spatial distribution and clusters of pancreatic cancer mortality in Shandong Province, China.
    Jiang F; Chu J; Chen X; Zhang J; Fu Z; Sun J; Lu Z; Guo X; Xu A
    Sci Rep; 2019 Sep; 9(1):12917. PubMed ID: 31501496
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Current diagnosis and treatment of pancreatic cancer in China.
    Guo X; Cui Z
    Pancreas; 2005 Jul; 31(1):13-22. PubMed ID: 15968242
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Young adulthood and adulthood adiposity in relation to incidence of pancreatic cancer: a prospective study of 0.5 million Chinese adults and a meta-analysis.
    Pang Y; Holmes MV; Kartsonaki C; Guo Y; Yang L; Bian Z; Chen Y; Bragg F; Iona A; Millwood IY; Chen J; Li L; Chen Z
    J Epidemiol Community Health; 2017 Nov; 71(11):1059-1067. PubMed ID: 28900029
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pancreatic cancer incidence and mortality patterns in china, 2009.
    Chen WQ; Liang D; Zhang SW; Zheng RS; He YT
    Asian Pac J Cancer Prev; 2013; 14(12):7321-4. PubMed ID: 24460295
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Epidemiological Characteristics of Pancreatic Cancer in China From 1990 to 2019.
    Zhu B; Wu X; Guo T; Guan N; Liu Y
    Cancer Control; 2021; 28():10732748211051536. PubMed ID: 34713730
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Report of Cancer Incidence and Mortality in China, 2014].
    Chen WQ; Li H; Sun KX; Zheng RS; Zhang SW; Zeng HM; Zou XN; Gu XY; He J
    Zhonghua Zhong Liu Za Zhi; 2018 Jan; 40(1):5-13. PubMed ID: 29365411
    [No Abstract]   [Full Text] [Related]  

  • 9. Pancreatic cancer mortality in China (1991-2000).
    Wang L; Yang GH; Lu XH; Huang ZJ; Li H
    World J Gastroenterol; 2003 Aug; 9(8):1819-23. PubMed ID: 12918128
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Current status and progress of pancreatic cancer in China.
    Lin QJ; Yang F; Jin C; Fu DL
    World J Gastroenterol; 2015 Jul; 21(26):7988-8003. PubMed ID: 26185370
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [The changing pancreatic cancer mortality in China (1991-2000)].
    Wang L; Yang GH; Li H; Lu XH
    Zhonghua Nei Ke Za Zhi; 2005 Jul; 44(7):509-13. PubMed ID: 16080841
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Trend analysis on morbidity and mortality of pancreatic cancer in China, 2005-2015].
    Cai J; Chen HD; Lu M; Zhang YH; Lu B; You L; Dai M; Zhao YP
    Zhonghua Liu Xing Bing Xue Za Zhi; 2021 May; 42(5):794-800. PubMed ID: 34814469
    [No Abstract]   [Full Text] [Related]  

  • 13. Incidence and mortality of pancreatic cancer on a rapid rise in Taiwan, 1999-2012.
    Tseng CM; Huang SP; Liao WC; Chiang CJ; Yang YW; Chang CY; Hsu YC; Chen HC; Chiang HS; Lin JT
    Cancer Epidemiol; 2017 Aug; 49():75-84. PubMed ID: 28600947
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Trend and prediction on the incidence of pancreatic cancer in China].
    Ma C; Jiang YX; Liu SZ; Quan PL; Sun XB; Zheng RS; Zhang SW; Chen WQ
    Zhonghua Liu Xing Bing Xue Za Zhi; 2013 Feb; 34(2):160-3. PubMed ID: 23751473
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of Life-Time Death Probability due to Malignant Tumors in Different Regions of China Based on Chinese Surveillance Sites.
    Yuan P; Chen TH; Lin XQ
    Asian Pac J Cancer Prev; 2019 Jul; 20(7):2021-2025. PubMed ID: 31350960
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Use of period analysis to provide a timely assessment of 5-year relative survival for pancreatic cancer patients from Taizhou, eastern China.
    Lu Y; He M; Lian L; Lei H; Cheng Y; Wang L; Chen T; Chen J
    BMC Cancer; 2023 Jul; 23(1):642. PubMed ID: 37430229
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prevalence of Germline Sequence Variations Among Patients With Pancreatic Cancer in China.
    Yin L; Wei J; Lu Z; Huang S; Gao H; Chen J; Guo F; Tu M; Xiao B; Xi C; Zhang K; Li Q; Wu J; Gao W; Jiang K; Yu J; Miao Y
    JAMA Netw Open; 2022 Feb; 5(2):e2148721. PubMed ID: 35171259
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Epidemiology of gastrointestinal and liver tumors.
    Herszényi L; Tulassay Z
    Eur Rev Med Pharmacol Sci; 2010 Apr; 14(4):249-58. PubMed ID: 20496531
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Socioeconomic Status in Relation to Risks of Major Gastrointestinal Cancers in Chinese Adults: A Prospective Study of 0.5 Million People.
    Pang Y; Kartsonaki C; Guo Y; Chen Y; Yang L; Bian Z; Bragg F; Millwood IY; Lv J; Yu C; Chen J; Li L; Holmes MV; Chen Z
    Cancer Epidemiol Biomarkers Prev; 2020 Apr; 29(4):823-831. PubMed ID: 31988070
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Statistical analysis of incidence and mortality of prostate cancer in China, 2015].
    Fu ZT; Guo XL; Zhang SW; Zheng RS; Zeng HM; Chen R; Wang SM; Sun KX; Wei WW; He J
    Zhonghua Zhong Liu Za Zhi; 2020 Sep; 42(9):718-722. PubMed ID: 32988152
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.